Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Evidence based chemotherapy for pediatric cancers].

M Kumagai1, Y Tsunematsu

  • 1Division of Hematology/Oncology, National Children's Hospital, Tokyo, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 4, 2000
PubMed
Summary

Pediatric cancer survival rates have risen to nearly 70% due to improved treatment strategies and supportive care, particularly for acute lymphoblastic leukemia (ALL) and Burkitt's lymphoma. However, advanced neuroblastoma and acute myeloid leukemia (AML) still require novel therapeutic approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-Genome Sequencing of the NARO World Rice Core Collection (WRC) as the Basis for Diversity and Association Studies.

Plant & cell physiology·2020
Same author

Impact of treatment planning with deformable image registration on dose distribution for carbon-ion beam lung treatment using a fixed irradiation port and rotating couch.

The British journal of radiology·2015
Same author

Hemodynamic evaluation of pancuronium and vecuronium by transesophageal echocardiography.

Journal of anesthesia·2013
Same author

Optical loss distribution in anodically oxidized alumina with a 2-D structure.

Applied optics·2010
Same author

Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumors.

International journal of clinical pharmacology and therapeutics·2010
Same author

Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.

Leukemia·2009

Area of Science:

  • Pediatric Oncology
  • Cancer Therapeutics
  • Clinical Trials

Context:

  • Significant advancements in pediatric cancer treatment have dramatically improved survival rates.
  • Refined treatment strategies and supportive care are key drivers of these successes.
  • Specific improvements noted in acute lymphoblastic leukemia (ALL) and Burkitt's lymphoma.

Purpose:

  • To review standard therapies for pediatric tumors.
  • To highlight evidence-based improvements in treatment strategies.
  • To identify areas needing further research and novel approaches for challenging pediatric cancers.

Summary:

  • Curability for pediatric cancers has reached nearly 70%, with over 70% of ALL patients and 90% of Burkitt's lymphoma patients now curable.
  • Wilms' tumor treatment has been optimized through clinical trials (NWTS), improving survival from 20% to 90% with shorter chemotherapy durations.

Related Experiment Videos

  • Advanced neuroblastoma and acute myeloid leukemia (AML) remain challenging, with less than 50% survival, indicating insufficient treatment refinements.

    • Impact:

    • Demonstrates the success of evidence-based medicine and clinical trials in pediatric oncology.
    • Provides a foundation for understanding current pediatric cancer treatment standards.
    • Identifies critical needs for developing new therapies for high-mortality pediatric cancers.